video popup of Co-founder & CTO Kilian Koepsell at RE•WORK Machine Intelligence Summit play button
Co-founder & CTO Kilian Koepsell at RE•WORK Machine Intelligence Summit
June 2016 | Berlin

Who We Are

Bay Labs is at the forefront of bringing deep learning advances to critical unsolved problems in healthcare. We have assembled an exceptional team of clinicians, engineers, and scientists who are developing breakthrough technologies in cardiovascular imaging and care to combat heart disease, the leading cause of death worldwide.

Learn more about our team

What We Do

Deep learning is a branch of artificial intelligence that follows decades of development from academic research, industry theory, and experimentation across an increasing image-centric and data-driven world. Today, deep learning technology is rapidly advancing numerous fields such as biomedicine, telecommunication, transportation, and finance.

Cardiovascular disease accounts for one in every four deaths in the United States—approximately 610,000 people every year, according to the CDC1.

1http://www.cdc.gov/heartdisease/facts.htm

Cardiovascular disease accounts for one in every four deaths in the United States—approximately 610,000 people every year, according to the CDC1.

1http://www.cdc.gov/heartdisease/facts.htm

Medicine is emerging as one of deep learning’s biggest areas of human impact: it is used for genomic testing and sequencing, diagnostic image analysis, drug development, and early detection of disease. Doctors in the U.S. are already using algorithmic support to improve the speed and quality of medical decisions.

At Bay Labs, we believe that deep learning has potential to dramatically impact the leading cause of death—cardiovascular disease. In order to serve the largest number of people, we aim to amplify the benefits of deep learning by providing high-performance algorithmic capabilities to assist with healthcare challenges on a global scale.

Our Partners

We work with a trusted network of world-class clinical and academic advisors. Current investors in Bay Labs are recognized leaders in venture capital.

Bay Labs’ technology complies with the national standards of the Health Insurance Portability and Accountability Act (HIPAA) for data anonymization and healthcare transactions.

  • <p>allina partner image</p>
  • <p>mhi partner image</p>
  • <p>national science foundation partner image</p>

Press

Business Wire
Oct 25, 2017
VentureBeat
May 10, 2017

Contact Us

Thank you for your interest in exploring the future of healthcare with us. We can’t wait to hear from you.

  • (# homeCtrl.contactFormError #)